Wegovy Cost in Connecticut (2026)
Affordability Score™ · CT
Wegovy (semaglutide) for weight management lists at $1,430/month in Connecticut. Prior authorization is common; savings cards can reduce copays to $25–$106/month for eligible patients.
Quick answer
Wegovy (semaglutide) lists at $1,430/month in Connecticut (2026). With commercial insurance and a savings card, many patients pay $25–$106/month — use the calculator below for your estimate.
Connecticut market notes for Wegovy (semaglutide)
For Wegovy (semaglutide, weight-management NDC) in Connecticut, expect BMI/comorbidity PA and more frequent obesity carve-outs than diabetes Ozempic — list prices look similar, coverage does not. Connecticut (CT) GLP-1 pricing follows national list prices adjusted by local pharmacy competition, employer formulary design, and whether Medicaid or Medicare Advantage dominates the insurance mix. Commercial plans in Connecticut commonly require prior authorization for obesity-indicated brands (Wegovy, Zepbound) while diabetes paths for Ozempic or Mounjaro clear more reliably when medically indicated. Manufacturer savings cards usually exclude government insurance—so Medicare, Medicaid, TRICARE, and VA patients in Connecticut need a separate model than the “$25/month” ads. Before you commit, get a written pharmacy quote for the exact NDC, confirm PA status with your insurer, and compare mail-order specialty copays against a local cash fill.
State cost index modifier: 1.06× · List ~$1,430/mo · Card path typically $25–$106/mo when eligible.
Free comparison
Compare GLP-1 options in Connecticut
See telehealth and pharmacy programs that may lower your monthly cost.
MetaDose may earn a fee through partner links. See our disclaimer.
Affordability audit
Step 1 — Pick your medication
Affordability Score™ is an educational estimate — not medical, insurance, or pharmacy advice.
All GLP-1 prices — CT
| Medication | List/mo | With card | Cash programs |
|---|---|---|---|
| Ozempic (semaglutide) | $1,027 | $25 – $106 | $370 – $529 |
| Wegovy (semaglutide) | $1,430 | $25 – $106 | $370 – $529 |
| Mounjaro (tirzepatide) | $1,179 | $25 – $106 | $370 – $529 |
| Zepbound (tirzepatide) | $1,151 | $25 – $106 | $370 – $529 |
Other GLP-1 drugs in Connecticut
What affects Wegovy (semaglutide) cost in Connecticut?
- Insurance type and whether your plan covers chronic weight management
- Prior authorization and BMI requirements
- Manufacturer savings card eligibility
- Connecticut regional cost index (modifier 1.06×)
- Compounded alternatives vs brand semaglutide
Medicare & Medicaid — Connecticut
Wegovy/Zepbound for weight loss are generally not covered by Medicare Part D as of 2026.
Related pages
Frequently Asked Questions
How much does Wegovy (semaglutide) cost in Connecticut without insurance?
List price in Connecticut is about $1,430/month. Cash discount programs may reduce cost to $370–$529/month; compounded semaglutide runs $211–$423/month via telehealth.
Does insurance cover Wegovy (semaglutide) in Connecticut?
Novo Nordisk markets Wegovy for chronic weight management. Commercial plans often require prior authorization; Medicare coverage depends on indication. See our <a href="/guides/glp1-prior-authorization/" class="text-accent-400 underline">prior auth guide</a>.
What is the cheapest way to get Wegovy in Connecticut?
With insurance + manufacturer savings card, eligible patients often pay $25–$106/month. Run the <a href="/affordability-audit/" class="text-accent-400 underline">Affordability Audit</a> for your scenario.
How does Connecticut compare to other states for Wegovy cost?
Connecticut uses a regional cost modifier of 1.06× vs national average. See <a href="/glp1-state-rankings/" class="text-accent-400 underline">50-state Affordability Rankings</a>.
How We Estimate GLP-1 Costs
MetaDose estimates combine manufacturer list prices (Novo Nordisk, Eli Lilly), NovoCare/LillyDirect cash programs, and state pharmacy cost indices — updated 2026-07-15.
Updated 2026-07-15. Novo Nordisk list prices, Lilly list prices, NovoCare/LillyDirect cash programs, GoodRx averages. Educational estimates only.